Header Logo

Eric Ko

Concepts (205)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Immunotherapy
6
2023
235
2.380
Why?
Radiotherapy
3
2019
63
1.820
Why?
Carcinoma, Non-Small-Cell Lung
3
2020
140
1.730
Why?
Head and Neck Neoplasms
5
2023
153
1.430
Why?
Prostatic Neoplasms
4
2017
320
1.200
Why?
Prostate-Specific Antigen
4
2017
67
1.080
Why?
Lung Neoplasms
3
2020
556
0.980
Why?
Combined Modality Therapy
7
2023
356
0.940
Why?
Brachytherapy
3
2013
41
0.820
Why?
Neoplasms
5
2019
1258
0.580
Why?
Prostatectomy
2
2017
46
0.570
Why?
Radiotherapy, Intensity-Modulated
3
2012
34
0.570
Why?
Adenocarcinoma
2
2011
324
0.550
Why?
Neoplasm Metastasis
5
2019
196
0.490
Why?
Neoplasm Staging
5
2018
455
0.470
Why?
Kallikreins
1
2013
9
0.450
Why?
Androgen Antagonists
1
2013
21
0.440
Why?
Carcinoma, Squamous Cell
2
2014
236
0.430
Why?
Induction Chemotherapy
1
2011
33
0.380
Why?
Radiation Injuries
1
2010
57
0.330
Why?
Antibodies, Monoclonal
6
2020
857
0.290
Why?
Antigens, Neoplasm
5
2006
135
0.290
Why?
Tumor Necrosis Factor Receptor Superfamily, Member 9
1
2007
3
0.290
Why?
Melanoma, Experimental
1
2007
42
0.280
Why?
Humans
25
2023
59817
0.270
Why?
Radiosurgery
2
2019
61
0.270
Why?
Immunotherapy, Adoptive
1
2007
86
0.270
Why?
Antineoplastic Agents
4
2017
647
0.260
Why?
Endothelial Cells
1
2007
176
0.260
Why?
Colonic Neoplasms
1
2007
215
0.250
Why?
Clinical Trials as Topic
2
2018
442
0.240
Why?
Dendritic Cells
2
2007
508
0.240
Why?
Pyrroles
3
2015
50
0.240
Why?
Indoles
3
2015
102
0.230
Why?
Tumor Microenvironment
2
2019
143
0.230
Why?
Immunotherapy, Active
1
2003
4
0.220
Why?
Epitopes
3
2019
295
0.220
Why?
Immunization, Passive
1
2003
100
0.220
Why?
Myeloid Cells
2
2015
92
0.200
Why?
CD8-Positive T-Lymphocytes
3
2019
647
0.190
Why?
Patient Selection
1
2023
448
0.190
Why?
Treatment Outcome
5
2018
5205
0.180
Why?
Survival Analysis
3
2012
553
0.180
Why?
Breast Neoplasms
1
2010
1128
0.180
Why?
Antibodies, Monoclonal, Humanized
2
2020
223
0.180
Why?
Antineoplastic Agents, Immunological
1
2020
42
0.170
Why?
CTLA-4 Antigen
1
2019
66
0.160
Why?
Middle Aged
9
2017
16402
0.160
Why?
Radiotherapy, Adjuvant
2
2016
61
0.160
Why?
Aged, 80 and over
6
2017
5149
0.160
Why?
Antigens
1
2019
146
0.160
Why?
Radium
1
2017
2
0.150
Why?
Tissue Extracts
1
2017
13
0.150
Why?
Prostatic Neoplasms, Castration-Resistant
1
2017
7
0.150
Why?
Male
10
2017
27771
0.150
Why?
Taxoids
1
2017
26
0.150
Why?
Organophosphorus Compounds
1
2017
32
0.140
Why?
Tumor Burden
1
2017
62
0.140
Why?
Salvage Therapy
1
2017
73
0.140
Why?
Receptors, Antigen, T-Cell
1
2019
280
0.140
Why?
Treatment Failure
2
2017
189
0.140
Why?
Organometallic Compounds
1
2017
64
0.140
Why?
Aged
7
2017
13463
0.140
Why?
Radiotherapy Dosage
2
2014
82
0.140
Why?
Neoplasm Grading
2
2017
75
0.130
Why?
Antibodies, Neoplasm
2
2006
27
0.130
Why?
CD4-Positive T-Lymphocytes
3
2015
619
0.120
Why?
Survival Rate
3
2017
790
0.120
Why?
Neoplasms, Squamous Cell
1
2014
7
0.120
Why?
T-Lymphocytes, Cytotoxic
2
2006
165
0.110
Why?
New York City
1
2013
75
0.110
Why?
Melanoma
3
2006
334
0.110
Why?
Disease-Free Survival
1
2013
233
0.110
Why?
Risk Factors
3
2014
5040
0.100
Why?
Retrospective Studies
3
2014
6040
0.100
Why?
Randomized Controlled Trials as Topic
1
2016
681
0.100
Why?
Radiation-Sensitizing Agents
1
2012
14
0.100
Why?
Radiotherapy, Image-Guided
1
2012
9
0.100
Why?
Robotic Surgical Procedures
1
2014
99
0.100
Why?
Chemoradiotherapy
1
2012
49
0.100
Why?
Small Molecule Libraries
1
2012
58
0.100
Why?
Drug Evaluation, Preclinical
1
2012
96
0.100
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2012
52
0.100
Why?
Palladium
1
2011
6
0.100
Why?
Radioisotopes
1
2011
24
0.100
Why?
Molecular Mimicry
3
2006
35
0.100
Why?
Iodine Radioisotopes
1
2011
52
0.100
Why?
Binding Sites, Antibody
3
2006
29
0.090
Why?
Multivariate Analysis
1
2013
925
0.090
Why?
Reference Values
1
2011
321
0.090
Why?
Risk
1
2011
374
0.090
Why?
Neovascularization, Pathologic
2
2010
138
0.090
Why?
Antibody Specificity
2
2007
99
0.090
Why?
Analysis of Variance
1
2011
577
0.090
Why?
Immune Tolerance
1
2010
169
0.080
Why?
Medication Adherence
1
2011
254
0.080
Why?
Female
7
2014
31100
0.080
Why?
Adult
4
2014
15882
0.080
Why?
Histones
1
2012
464
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2012
405
0.080
Why?
Hybrid Cells
1
2007
19
0.070
Why?
Mice
6
2007
10309
0.070
Why?
Animals
9
2012
19722
0.070
Why?
HIV Infections
1
2014
927
0.070
Why?
Prevalence
1
2010
1288
0.060
Why?
HLA-A2 Antigen
1
2006
65
0.060
Why?
Immunotoxins
1
2005
7
0.060
Why?
Antibodies, Anti-Idiotypic
1
2005
34
0.060
Why?
CD4 Antigens
1
2006
156
0.060
Why?
Interleukin-2
1
2005
164
0.060
Why?
Antibody Affinity
1
2004
18
0.060
Why?
Young Adult
2
2012
4365
0.060
Why?
Immunoglobulin Variable Region
1
2004
32
0.060
Why?
Adolescent
2
2012
5939
0.060
Why?
Cohort Studies
1
2010
2461
0.060
Why?
Peptide Fragments
1
2005
353
0.050
Why?
Cell Line, Tumor
4
2012
1379
0.050
Why?
Follow-Up Studies
3
2014
2341
0.050
Why?
CD11b Antigen
2
2015
21
0.050
Why?
Risk Assessment
1
2010
1918
0.050
Why?
Peptides
1
2006
546
0.050
Why?
Cell Survival
2
2015
557
0.050
Why?
United States
2
2014
7569
0.050
Why?
Mice, Inbred C57BL
1
2007
3207
0.040
Why?
Prognosis
2
2012
1584
0.040
Why?
Sialic Acid Binding Ig-like Lectin 3
1
2015
1
0.030
Why?
STAT3 Transcription Factor
1
2015
68
0.030
Why?
Neck Dissection
1
2014
19
0.030
Why?
Leukocytes, Mononuclear
1
2015
238
0.030
Why?
Chemotherapy, Adjuvant
1
2014
77
0.030
Why?
Immune System
1
2015
129
0.030
Why?
Tertiary Care Centers
1
2014
102
0.030
Why?
Mice, Inbred BALB C
2
2005
880
0.030
Why?
Flow Cytometry
1
2015
638
0.030
Why?
Immunosuppressive Agents
1
2015
303
0.030
Why?
Monocytes
1
2015
344
0.030
Why?
Surgical Flaps
1
2014
102
0.030
Why?
Phosphorylation
1
2015
860
0.030
Why?
Ribonucleotide Reductases
1
2012
7
0.030
Why?
Radiation, Ionizing
1
2012
16
0.030
Why?
Papillomavirus Infections
1
2014
127
0.020
Why?
Cetuximab
1
2012
8
0.020
Why?
Hydroxyurea
1
2012
22
0.020
Why?
Eye
1
2012
54
0.020
Why?
Fluorouracil
1
2012
54
0.020
Why?
Cell Transformation, Neoplastic
1
2012
195
0.020
Why?
Cell Proliferation
1
2015
942
0.020
Why?
Alcoholism
1
2014
308
0.020
Why?
Disease Progression
1
2015
1052
0.020
Why?
DNA Repair
1
2012
233
0.020
Why?
Proto-Oncogene Proteins
1
2012
316
0.020
Why?
Kinetics
1
2012
735
0.020
Why?
DNA Damage
1
2012
281
0.020
Why?
Cell Cycle
1
2012
379
0.020
Why?
Proto-Oncogene Proteins c-kit
1
2010
32
0.020
Why?
Cell Cycle Proteins
1
2012
388
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2012
483
0.020
Why?
Smoking
1
2014
830
0.020
Why?
Gene Expression Profiling
1
2012
707
0.020
Why?
Vascular Endothelial Growth Factor A
1
2010
200
0.020
Why?
Drosophila melanogaster
1
2012
480
0.020
Why?
DNA
1
2012
793
0.020
Why?
Apoptosis
1
2012
1040
0.020
Why?
Time Factors
1
2014
3590
0.020
Why?
Proteoglycans
1
2006
33
0.020
Why?
Antibody-Dependent Cell Cytotoxicity
1
2006
28
0.020
Why?
Binding, Competitive
1
2006
100
0.020
Why?
Enterotoxins
1
2006
21
0.020
Why?
Laminin
1
2006
76
0.020
Why?
Antigens, Differentiation, T-Lymphocyte
1
2006
106
0.020
Why?
Drug Combinations
1
2006
137
0.020
Why?
Cancer Vaccines
1
2006
48
0.020
Why?
Hemocyanins
1
2005
23
0.020
Why?
Collagen
1
2006
119
0.020
Why?
Cytotoxicity, Immunologic
1
2006
144
0.020
Why?
Lectins, C-Type
1
2006
78
0.020
Why?
Inovirus
1
2005
2
0.020
Why?
Immunization
1
2006
127
0.020
Why?
Hypersensitivity, Delayed
1
2005
22
0.020
Why?
Rabbits
1
2006
330
0.020
Why?
Peptide Library
1
2005
35
0.020
Why?
Complement System Proteins
1
2006
127
0.020
Why?
Immunization, Secondary
1
2005
46
0.020
Why?
Molecular Weight
1
2005
189
0.020
Why?
Disease Models, Animal
1
2012
2079
0.020
Why?
Adoptive Transfer
1
2005
145
0.020
Why?
Up-Regulation
1
2006
364
0.010
Why?
Antigens, CD
1
2006
343
0.010
Why?
Lymphocytes
1
2005
193
0.010
Why?
Gene Library
1
2004
99
0.010
Why?
Cell Movement
1
2006
424
0.010
Why?
Immunoglobulin G
1
2006
453
0.010
Why?
Proto-Oncogene Proteins c-myc
1
2004
99
0.010
Why?
Cloning, Molecular
1
2004
385
0.010
Why?
Adjuvants, Immunologic
1
2005
228
0.010
Why?
Interferon-gamma
1
2006
548
0.010
Why?
Recombinant Fusion Proteins
1
2005
502
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2004
449
0.010
Why?
Lymphocyte Activation
1
2006
739
0.010
Why?
Recombinant Proteins
1
2004
696
0.010
Why?
Mice, Transgenic
1
2006
1225
0.010
Why?
Sensitivity and Specificity
1
2004
1098
0.010
Why?
Cell Line
1
2006
2015
0.010
Why?
Protein Binding
1
2004
1559
0.010
Why?
Reproducibility of Results
1
2004
1559
0.010
Why?
Ko's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (205)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_